Is South Africa Implementing an Mpox Vaccination Program to Combat Spread?
Click to start listening
Synopsis
As mpox cases escalate in South Africa, the National Department of Health has announced a new vaccination initiative targeting the disease's spread. This crucial program aims to protect vulnerable populations and encourage public vigilance.
Key Takeaways
- Vaccination is crucial for controlling mpox spread.
- High-risk individuals will receive priority for vaccination.
- Public health facilities will administer the mpox vaccine.
- Community vigilance is essential for identifying symptoms.
- 10,500 doses have been allocated to South Africa for this initiative.
Johannesburg, July 18 (NationPress) With the ongoing rise in laboratory-confirmed mpox cases in South Africa, the National Department of Health has unveiled its initiative to launch a vaccination program aimed at controlling the spread of this disease.
“Vaccination is essential for managing the transmission of this preventable illness, with those vaccinated enjoying protection against infection and severe complications,” stated Health Department spokesperson Foster Mohale on Wednesday.
In light of the recent identification of two additional cases in the Western Cape and Gauteng, the department confirmed that the mpox vaccine will be accessible in the three provinces most affected, including KwaZulu-Natal.
According to the department, ten mpox cases have been documented since the beginning of 2025. The outbreak in South Africa initiated in May 2024, with over 20 cases reported during that time.
Residents in the three provinces most impacted will be able to receive the vaccine at public health facilities.
“The public is strongly encouraged to remain vigilant for symptoms of mpox, and those who believe they may be at risk should consult their nearest health facility or healthcare provider for screening and testing, as well as to determine their eligibility for this life-saving vaccine,” Mohale advised.
Vaccine distribution will prioritize individuals at higher risk of contracting the disease, including those who have had contact with mpox patients, individuals engaging in sexual activities with multiple partners, and travelers to countries with elevated mpox case numbers. Additionally, vaccination will be available for pregnant women and children over the age of two, as reported by Xinhua news agency.
The health department of South Africa has received approximately 10,500 doses of the mpox vaccine from the Africa Centres for Disease Control through the Access and Allocation Mechanism for Mpox. This initiative is part of the efforts to address outbreaks throughout the African continent, established by the World Health Organization in collaboration with its member states.
Point of View
It is imperative to recognize the proactive steps being taken by South Africa's health authorities in response to the mpox outbreak. The vaccination program reflects a commitment to public health, prioritizing at-risk individuals and fostering community awareness.
NationPress
20/07/2025
Frequently Asked Questions
What is mpox?
Mpox is a contagious disease caused by the mpox virus, which can lead to severe health complications if left untreated. Vaccination is a key preventive measure.
Who is eligible for the mpox vaccine?
Individuals at high risk, including those with recent contact with mpox patients, those with multiple sexual partners, and pregnant women, are prioritized for vaccination.
Where can I get vaccinated?
The mpox vaccine will be available at public health facilities in the three most affected provinces: Western Cape, Gauteng, and KwaZulu-Natal.
How many cases of mpox have been reported?
As of now, there have been a total of ten recorded mpox cases since the start of 2025, with an outbreak beginning in May 2024.
